Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 16, 2015 | ElMindA | $28.0M Series C | — | HealthCrest, OurCrowd, Tianqiao Chen 陈天桥, Robert Kraft, Wexford Capital, Bill Hambrecht |
| Feb 26, 2013 | Brickell Biotech | $7.0M Series B | Paul Kang | — |
| May 1, 2012 | Mitralign | $35.0M Series D | Forbion | 4See Ventures, Giza Venture Capital, Johnson & Johnson Innovation, Medtronic, Oakwood Medical Investors, Orchestra Medical Ventures, Oxford Bioscience Partners, Saints Capital, Triathlon Medical Ventures |